IBA acquires ORA expanding its strategic leadership in Nuclear Medicine
Louvain-La-Neuve, Belgium, 19 December 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, acquires ORA, a global trailblazer in radiochemistry based in Belgium. This acquisition emphasizes IBA’s long-term commitment to the fast-developing and promising field of nuclear medicine. It reinforces IBA’s position […]
IBA acquires ORA expanding its strategic leadership in Nuclear Medicine Read More »


















































